Clinical trials recruiting for COPD Exacerbation Acute

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• COPD-ICU Multicentre Prospective Observational Register
  NCT05734365 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
  NCT05012033 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Multiparametric Home Telemonitoring of Patients With Chronic Obstructive Pulmonary Disease Exacerbation
  NCT06331416 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Rademikibart IV for Acute Asthma and COPD Exacerbation
  NCT07705737 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 4 locations
• Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease
  NCT05703919 · Phase: Phase 4 · Ages: 40 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for COPD Exacerbation Acute often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for COPD Exacerbation Acute trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.